Skip to Content
Merck
  • Making connections between ultrafast protein folding kinetics and molecular dynamics simulations.

Making connections between ultrafast protein folding kinetics and molecular dynamics simulations.

Proceedings of the National Academy of Sciences of the United States of America (2011-03-29)
Troy Cellmer, Marco Buscaglia, Eric R Henry, James Hofrichter, William A Eaton
ABSTRACT

Determining the rate of forming the truly folded conformation of ultrafast folding proteins is an important issue for both experiments and simulations. The double-norleucine mutant of the 35-residue villin subdomain is the focus of recent computer simulations with atomistic molecular dynamics because it is currently the fastest folding protein. The folding kinetics of this protein have been measured in laser temperature-jump experiments using tryptophan fluorescence as a probe of overall folding. The conclusion from the simulations, however, is that the rate determined by fluorescence is significantly larger than the rate of overall folding. We have therefore employed an independent experimental method to determine the folding rate. The decay of the tryptophan triplet-state in photoselection experiments was used to monitor the change in the unfolded population for a sequence of the villin subdomain with one amino acid difference from that of the laser temperature-jump experiments, but with almost identical equilibrium properties. Folding times obtained in a two-state analysis of the results from the two methods at denaturant concentrations varying from 1.5-6.0 M guanidinium chloride are in excellent agreement, with an average difference of only 20%. Polynomial extrapolation of all the data to zero denaturant yields a folding time of 220 (+100,-70) ns at 283 K, suggesting that under these conditions the barrier between folded and unfolded states has effectively disappeared--the so-called "downhill scenario."

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Norleucine, suitable for amino acid analysis, BioReagent
Sigma-Aldrich
L-Norleucine, ≥98% (TLC)